Paper Review Records
All Paper Review Records
25 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
63
days
PBPK‐Based Prediction of Oliceridine Exposure in Breast Milk and Relative Infant Dose During the First 24 h After Cesarean Delivery
Authors
Yixi Ding; Ke Liu; Shuaishuai Zhang; Yanxu Zhang; Xin Tan; Weimin XuShow moreShow less
Affiliations
1. School of Anesthesiology Shandong Second Medical University Weifang Shandong China; 2. Department of Anesthesiology Shengli Oilfield Central Hospital Dongying Shandong ChinaShow moreShow less
85
days
Simulation‐Based Evaluation of Busulfan Sampling Strategies in Adults and Adolescents Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
Authors
Zhiyuan Tan; Federica R. Achini‐Gutzwiller; Arjan C. Lankester; Joost G. K. van der Hem; Peter A. von dem Borne; Dirk Jan. A. R. Moes; Tim PreijersShow moreShow less
Affiliations
1. Department of Clinical Pharmacy & Toxicology Leiden University Medical Center Leiden The Netherlands; 2. Division of Systems Pharmacology and Pharmacy Leiden Academic Center for Drug Research Leiden University Leiden The Netherlands; 3. Department of Pediatrics Leiden University Medical Center Leiden The Netherlands; 4. Department of Hematology Leiden University Medical Center Leiden The Netherlands; 5. Department of Hospital Pharmacy Rotterdam Erasmus Medical Center Rotterdam The NetherlandsShow moreShow less
215
days
Dose Selection for Ceftibuten Combined with Avibactam Tomilopil, a Potential Oral Alternative to Carbapenems for Patients with Complicated Urinary Tract Infections
Authors
Siddhee A. Sahasrabudhe; Satoshi Shoji; Abhijeet S. Jakate; Bisrat K. Abraham; Sima S. Toussi; Benjamin J. Maligalig; Amanda S. Darekar; Sakambari Tripathy; Constantino Kantaridis; Josue K. Mfopou; Oxana Selivanova; Arthur Bergman; Negar Niki Alami; Ravi Shankar P. SinghShow moreShow less
Affiliations
1. Pfizer Inc. Cambridge MA USA; 2. Pfizer R&D Japan Tokyo Japan; 3. Pfizer Inc. New York NY USA; 4. Pfizer Inc. Pearl River NY USA; 5. Pfizer Inc. Makati City Philippines; 6. Pfizer R&D UK Ltd. Tadworth Surrey UK; 7. Pfizer Inc. South San Francisco CA USA; 8. Pfizer CRU Brussels Belgium; 9. Pfizer Inc. Groton CT USAShow moreShow less
49
days
Bayesian‐Estimated Vancomycin AUC24 as a Near‐Term Renal Risk Signal after Therapeutic Drug Monitoring: A Multicenter Cohort Study
Authors
Tran Van Anh; Bui Thi Tham; Tran Thi Ngan; Nguyen Duc Long,; Nguyen Huong Giang; Nguyen Hoang Anh; Vu Dinh Hoa; Hoang Van Dung; Nguyen Thi Thu PhuongShow moreShow less
Affiliations
1. Faculty of Pharmacy Hai Phong University of Medicine and Pharmacy Hai Phong Viet Nam; 2. Department of Pharmacy Hai Phong International Hospital Hai Phong Viet Nam; 3. Hanoi University of Pharmacy Hanoi Viet Nam; 4. Vietnam National Drug Information and Adverse Drug Reaction Monitoring Centre Hanoi Viet Nam; 5. Department of Internal Medicine Hai Phong International Hospital Hai Phong Viet Nam; 6. Department of Internal Medicine Hai Phong University of Medicine and Pharmacy Hai Phong Viet NamShow moreShow less
59
days
Tamoxifen Therapy Is Associated With Altered Intestinal P‐Glycoprotein Activity In Vivo
Authors
Álef Machado Gomes Pego; Fernanda de Lima Moreira; Ana Flavia Mendes Batista; Adriana Rocha; Maria Paula Marques Pereira; Eduardo Barbosa Coelho; Jurandyr Moreira de Andrade; Geraldo Duarte; Vera Lucia Lanchote; João Paulo Bianchi XimenezShow moreShow less
Affiliations
1. School of Pharmaceutical Sciences of Ribeirão Preto University of São Paulo Ribeirão Preto São Paulo Brazil; 2. Faculty of Pharmacy Federal University of Rio de Janeiro Rio de Janeiro Rio de Janeiro Brazil; 3. Ribeirão Preto Medical School University of São Paulo Ribeirão Preto São Paulo BrazilShow moreShow less
69
days
PBPK Modeling of Esomeprazole to Support Adolescent Pharmacokinetic Extrapolation and Label Extension in Chinese Patients With Gastroesophageal Reflux Disease (GERD)
Authors
Yuwen Jin; Junjie Ding; Xiaohan Hua; Wei Duan; Mo Chen; Zhaohui Zhou; Ramesh V Pandherpur; Jin Dong; Sharma Pradeep; Peiming Ma; Weifeng Tang; Diansong ZhouShow moreShow less
Affiliations
1. Clinical Pharmacology R&D China AstraZeneca Shanghai China; 2. Respiratory & Immunology R&D China AstraZeneca Shanghai China; 3. Biometrics and Data Science R&D China AstraZeneca Shanghai China; 4. Clinical Safety R&D China AstraZeneca Shanghai China; 5. Clinical Development BioPharmaceuticals R&D AstraZeneca Bengaluru India; 6. Clinical Pharmacology & Quantitative Pharmacology Clinical Pharmacology and Safety Sciences R&D, AstraZeneca Gaithersburg Maryland USA; 7. Clinical Pharmacology & Quantitative Pharmacology Clinical Pharmacology and Safety Sciences R&D, AstraZeneca Cambridge UK; 8. Clinical Pharmacology & Quantitative Pharmacology Clinical Pharmacology and Safety Sciences R&D, AstraZeneca Waltham Massachusetts USAShow moreShow less
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
Client
I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?
CrushSCI
Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.
- Suggested title
- Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment
- Database shortlist
- Environmental Technology & Innovation
SampleLatest 5 valid paper samples from 2026
Average review62 days
Median65 days